Reagent and discovery-tool suppliers at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
38 reagent and discovery-tool suppliers are at Festival of Biologics 2026 — 13 presentations on the program and 37 with a booth in the exhibit hall. Most represented: YUMAB (3 on the program), FairJourney Biologics (2 on the program), Adimab (1 on the program). 37 of them have their own page in this guide. As of Sep 26, 2026.
Topic
Top represented
Showing 1–16 of 38 organizations
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
YUMAB Braunschweig, Germany | |
Antibody discovery and development company generating fully human antibodies for partners from human antibody libraries. | Booth Exhibiting (no floor booth listed) Chair Tue Oct 13 14:05 Talk Wed Oct 14 12:10 Advancing Antibody Discovery Through Paired Libraries Capturing millions of single B cells to build antibody libraries that keep each cell's natural heavy and light chain pairing. Keynote Thu Oct 15 09:55 Hunting Hidden Targets: Developing Highly Specific Antibodies Against Peptide-HLA Complexes Antibodies that recognise protein fragments from inside cells displayed on the cell surface, and how to stop them binding the wrong targets. |
FB FairJourney Biologics Porto, Portugal | |
Antibody discovery and engineering partner working on behalf of biotech and pharma clients. | Booth Exhibiting (no floor booth listed) Panel Tue Oct 13 17:30 Panel Discussion: Next Generation Antibody Formats Where antibody drug design is heading, from two-target antibodies and antibody-drug conjugates to AI's role in engineering them. |
Adimab Lebanon, NH | |
Yeast-based antibody discovery and optimization platform that partners with biopharma companies on therapeutic antibody and bispecific programs. | Booth Exhibiting (no floor booth listed) Talk Wed Oct 14 12:10 Adimab: Multispecific Antibodies Beyond Monospecific Therapies Why single-target antibodies fall short for some patients, and how ready-made parts that bind T cells speed design of multi-target antibodies. |
ATUM Newark, CA | |
Gene synthesis, protein engineering and Leap-In transposase cell line development tools and services for biologics developers. | Booth Exhibiting at Booth 278 Talk Wed Oct 14 11:50 Overcoming Manufacturing Bottlenecks in Multispecific Design via Native Scaffold Engineering How keeping the natural antibody shape, with few mutations, helps multi-target antibodies assemble correctly and stay easy to make. |
genOway Lyon, France | |
Provides humanized mouse models and other preclinical models and solutions to bridge preclinical research and clinical success. | Booth Exhibiting at Booth 399 Talk Tue Oct 13 15:10 Advancing T‑Cell Engagers: Addressing Key Efficacy and Safety Challenges How mice with a human immune system test T cell engagers, tracking immune cells entering tumors and myeloid cells' role in cytokine release. |
Through its Specifica business, supplies Generation 3 antibody libraries for phage and yeast display discovery of drug-like antibodies. | Booth Exhibiting at Booth 290 Talk Tue Oct 13 17:30 Beyond recombinant proteins: therapeutic antibody discovery strategies for cells, GPCRs, and challenging targets How lab-made antibody libraries now rival animal immunization and find antibodies to hard targets like G protein-coupled receptors on live cells. |
Makes highly active recombinant proteins and enzymes for antibody discovery, immunotherapy, gene therapy and mRNA therapeutics. | Booth Exhibiting at Booth 284 Talk Tue Oct 13 14:50 From Complex Membrane Proteins to Emerging Targets: Unlocking New Frontiers in Antibody Discovery How showing full-length membrane proteins in virus-like particles and nanodiscs, tiny membrane patches, helps find antibodies to hard targets like ion channels. |
Harbour BioMed's discovery company, offering Harbour Mice antibody platforms (H2L2, HCAb) and discovery services for antibodies, multispecifics, ADCs and CAR-T binders. | Booth Exhibiting at Booth 424 Keynote Wed Oct 14 09:30 Novel Next-generation Multispecifics, CAR-Ts & ADCs from H2L2 & HCAb Harbour Mice® How mice that make human antibodies, including heavy-chain-only ones, are used to build multi-target antibodies, CAR-T cells and antibody–drug conjugates for cancer. Bispecifics & multispecificsADCs & armed antibodies |
Nuclera Cambridge, United Kingdom | |
Makes the eProtein Discovery benchtop system, which uses cell-free expression to give researchers rapid access to functional proteins for drug discovery. | Booth Exhibiting at Booth 114 Talk Tue Oct 13 14:30 Testing Engineered Antibodies at Scale: Cell-Free Screening of AI Designed Panels How making full antibodies without living cells quickly shows which AI-designed variants bind, closely matching slower tests in mammalian cells. |
Twist Bioscience South San Francisco, CA | |
Makes synthetic DNA and gene libraries and offers antibody discovery and multispecific development, including the B-Body platform. | Booth Exhibiting at Booth 349 Talk Tue Oct 13 13:10 Accelerating multispecific antibody discovery & development with the B-Body platform How to build antibodies that bind two or more targets without mismatched light chains and purify them like ordinary antibodies. Bispecifics & multispecifics |
SB Salipro Biotech Stockholm, Sweden | |
Uses its Salipro nanoparticle platform to stabilize membrane proteins such as GPCRs for antibody and drug discovery. | Talk Thu Oct 15 11:20 Overcoming GPCR Antibody Discovery Challenges: Next-Generation CXCR4 Antibodies How extracting a cancer-linked chemokine receptor in its natural form yielded stronger blocking antibodies than an earlier candidate dropped in the clinic. |
AB Avenue Biosciences San Francisco, CA | |
San Francisco start-up accelerating discovery and development of protein biologics by removing protein production barriers. | Booth Exhibiting at Booth S17 |
Supplies gene synthesis, custom proteins, antibodies and other research reagents and services. | Booth Exhibiting at Booth 286 |
Designs synthetic mammalian promoters and signal peptides that let biologics developers control how much protein is expressed, and where. | Booth Exhibiting at Booth S9 |
Supplier of recombinant target proteins and related reagents for antibody discovery and cell therapy development. | Booth Exhibiting at Booth 212 |
Asimov Boston, MA | |
Booth Exhibiting at Booth 342 |
Instantly find 20 buyers from reagent and discovery-tool suppliers
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Festival of Biologics 2026 by
Organization type
Topic
- Antibody & protein engineering 67
- AI & computational design 38
- Bispecifics & multispecifics 13
- ADCs & armed antibodies 18
- Immunotherapy & oncology 44
- Cell & gene therapy 28
- Therapeutic vaccines 13
- Peptides & GLP-1 7
- Bioprocessing & manufacturing 87
- CMC, formulation & analytics 58
- Clinical development 45
- Regulation & market access 40
Exhibit hall
Everyone
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction